Thomas Quast

University of Bonn — Germany

Immunology and Microbiology · Life Sciences

26h-index3.3kcitations73works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(30), Cancer Immunotherapy and Biomarkers(20), T-cell and B-cell Immunology(11), Adenosine and Purinergic Signaling(11), Immune Cell Function and Interaction(10)

Publications73 total

Differential impact of high-salt levels in vitro and in vivo on macrophage core functions
Molecular Biology Reports·2024· 4 citedOpen Access
Differential impact of high-salt levels in vitro and in vivo on macrophage core functions
Research Square (Research Square)·2023· 1 citedOpen Access
Table S7 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Table S3 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Table S5 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Data from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Table S3 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Table S6 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Table S7 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Supplementary Methods from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Table S6 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Tables S1, S2, S4, S8, S9 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Supplementary Methods from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Legends to Suppl. Figures from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Supplementary Figure 1 to 7 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Data from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Table S5 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Supplementary Figure 1 to 7 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Tables S1, S2, S4, S8, S9 from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
Legends to Suppl. Figures from MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Waldemar Kolanus(33), Michael Hölzel(9), Thomas Tüting(9), Tobias Bald(8), Nicole Glodde(8), Dorys Lopez-Ramos(8), Dirk Schadendorf(8), Sven Burgdorf(7), Jonathan L. Schmid‐Burgk(7), Bartomeu Bibiloni Ramis(7), Arabella Young(7), Shin Foong Ngiow(7), Daniel Nettersheim(7), Hubert Schorle(7), Georgina V. Long(7), Jason Madore(7), Richard A. Scolyer(7), Antoni Ribas(7), Mark J. Smyth(7), Paul C. Tumeh(7)